Pages
Products
PGK-GFP Lentivirus

PGK-GFP Lentivirus

Cat.No. :  LV00994Z

Titer: ≥1*10^7 TU/mL / ≥1*10^8 TU/mL / ≥1*10^9 TU/mL Size: 100 ul/500 ul/1 mL

Storage:  -80℃ Shipping:  Frozen on dry ice

Inquire for Price

Lentivirus Particle Information

Quality Control

Cat. No. LV00994Z
Description This lentivirus contains EGFP under the control of PGK promoter.
Target Gene GFP
Titer Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc.
Size Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Lentivirus is a type of retrovirus with a particle size of 80-120nm. It consists of a single-stranded RNA sequence that is transcribed into DNA and can be integrated into the host genome, resulting in persistent infection. Most lentiviral vectors are derived from HIV-1 and retain the ability to integrate into the genome of infected cells. LV is very popular in clinical applications because it can more effectively transduce non-proliferating or slowly proliferating cells. Recently, several clinical trials have used third-generation self-inactivating LV to introduce genes into hematopoietic stem cells to treat primary immunodeficiency or hemoglobinopathy. The most common application of LV is to introduce genes through chimeric antigen receptor (CAR) or cloned T cell receptor delivery to produce anti-tumor immunity. The lentiviral vector currently used in cell therapy is derived from HIV-1, and its prototype contains nine key viral genes, namely: gag, pol, env, tat, rev, vif, vpr, vpu, nef. Among them, the gag gene can encode the core protein required by the virus; the pol gene encodes the enzyme required for viral replication; and the env gene encodes the envelope glycoprotein of the virus. These three genes encode structural proteins and proteases, which are key genes to ensure the ability of the virus to replicate and determine the targeting of the virus to infect the host. Some cis-acting elements are also required in the process of viral expression, including long terminal repeats (LTRs), TAT activation region (TAR), splicing donor and receptor sites, packaging and dimerization signals (Ψ), Rev response elements (RRE), and central and terminal polypurine regions (PPT). In theory, we need to insert the target gene we need to express with lentivirus in the middle of the LTRs at both ends, send it into the target cells and express it to achieve the expression of exogenous genes.

Using a lentiviral-mediated labeling approach, researchers investigated whether the adult hippocampus retains persistent self-renewing neural stem cells (NSCs). A single injection of a lentiviral vector expressing green fluorescent protein (LV PGK-GFP) into the subgranular zone (SGZ) of the adult hippocampus allowed for efficient, stable, and long-term labeling of self-renewing NSCs and their progeny. Interestingly, a subset of labeled cells showed the ability to proliferate multiple times and give rise to Sox2+ cells, clearly demonstrating that NSCs have the capacity to self-renew over a long period of time (up to 6 months). Furthermore, using GFP+ cells isolated from the SGZ of mice that had received LV PGK-GFP injections 3 months earlier, researchers demonstrated that some GFP+ cells exhibited basic properties of NSCs, such as self-renewal and multipotency. Lentiviral (LV)-mediated labeling studies revealed that hippocampal NSCs are not responsible for the burst of astrocyte formation, suggesting that signals released by impaired perforant pathways do not affect NSC fate decisions. Therefore, the gene delivery system using LVs is a unique approach to understand the complex nature of NSCs and may have a translational impact in gene therapy by effectively targeting NSCs.

To test whether LV PGK-GFP was successfully transduced into NSCs with long-term proliferative capacity, the researchers introduced BrdU 6 months after LV PGK-GFP injection. The hippocampus was then examined 24 hours after the last BrdU injection to identify proliferating cells. The researchers found that 6.25±1.8% of GFP+ cells in the SGZ of the DG were positive for BrdU. This observation suggests that the initially targeted cells or their progeny maintained their proliferative capacity over a 6-month period (Figure 1A). 10±1.4% of these GFP/BrdU double-labeled cells expressed the SOX2 marker (Figure 1B), which is known to represent self-renewing and multipotent NSCs. Doublecortin (DCX), a transient marker that marks neuroblasts and immature neurons, was used to measure the continuous neurogenesis of GFP+ cells. Indeed, they observed both GFP/DCX double-labeled cells (26.8±2% of GFP+ cells; n = 3 Figure 1C) and GFP/BrdU/DCX cells triple-labeled cells (60±2.3% n = 3; Figure 1D). Interestingly, these results together suggest that NSCs are continuously generated from targeted GFP+ cells and are actively generating neuroblasts even 6 months after LV injection.

Figure 1. A long-lasting NSC population in the adult hippocampus.Figure 1. A long-lasting NSC population in the adult hippocampus. (Suh H, et al. 2018)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction

CBpromise

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER